Greenwich LifeSciences (GLSI) Stock Highlights

12.39 | -1.04%

2024-12-21 06:23:53

Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels.

Statistics

Range Today

12.15 12.77

Volume Today 72.6K

Range 1 Year

8 21.44

Volume 1 Year 9.69M

Range 3 Year

6.82 30.36

Volume 3 Year 47.64M

Range 10 Year

3.26 158.07

Volume 10 Year 154.07M

Highlights

Market Capitalization 189.15M (small)

Floating Shares 5.92M

Current Price 12.39

Price To Earnings -16.83

Price To Book 31.98

Earnings Per Share -0.83

Payout Ratio 0%

Performance

Latest -1.04%

1 Month -3.5%

3 Months -16.73%

6 Months -21.43%

1 Year +20.64%

3 Years -58.23%

5 Years +115.48%

10 Years +115.48%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.